Enliven Therapeutics, Inc. (ELVN) vs Precigen, Inc. (PGEN)
A side-by-side comparison of Enliven Therapeutics, Inc. and Precigen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELVN
Enliven Therapeutics, Inc.
$42.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PGEN
Precigen, Inc.
$7.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ELVN vs PGEN
growth of $100 · dividends reinvested · last 7yELVN -24.2% (-3.9%/yr)PGEN +224.5% (+18.3%/yr)PGEN compounded faster over this window
ELVN PGEN
ELVN vs PGEN: by the numbers
- •ELVN is the larger company ($3.03B vs $2.69B market cap).
- •Both run net losses; ELVN's is the smaller (0.00% vs -183.98% net margin).
Metrics side by side
Valuation
| Metric | ELVN | PGEN |
|---|---|---|
| Forward P/E | N/A | 44.06 |
| P/S ratio | N/A | 31.40 |
| P/B ratio | 3.38 | 61.77 |
Profitability
| Metric | ELVN | PGEN |
|---|---|---|
| Gross margin | 0.00% | 37.05% |
| Operating margin | 0.00% | -1100.78% |
| Net margin | 0.00% | -183.98% |
| ROE | -11.83% | -361.91% |
| ROIC | -13.88% | -28.02% |
Growth (annualized)
| Metric | ELVN | PGEN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -21.26% |
| Total return CAGR (5Y) | 24.57% | 8.79% |
Frequently asked
- How have ELVN and PGEN total returns compared?
- Over the past 5 years, ELVN delivered 24.57% and PGEN delivered 8.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.